HOME Top Market Reports In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to 2021

In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: December 2016
Report Code: MD 3609

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global in vitro diagnostics market is valued at USD 60.22 Billion in 2016. This market is expected to grow at a CAGR of 5.5% during the forecast period (2016–2021) to reach USD 78.74 Billion by 2021. The growing acceptance of molecular diagnostics in personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers are key factors driving market growth. Untapped emerging regions showcase new growth opportunities for this market. However, market growth is restrained by the lack of reimbursement and increasing healthcare cost.

This research study involved the extensive usage of both primary and secondary data sources as well as various factors affecting the industry, including the regulatory landscape; competitive scenario; historic data; current trends in the market; technological innovations and upcoming technologies; and market drivers, restraints, opportunities, and challenges.

In this report, the in vitro diagnostics market is segmented by products & services, technology, application, end user, and region. Based on application, the market is segmented into diabetes, infectious diseases, oncology/cancer, cardiology, HIV/AIDS, autoimmune diseases, nephrology, drug testing/pharmacogenomics, and others. The infectious diseases segment accounted for the largest share of the market in 2015, owing to the rising incidence of infectious disorder such as rise in the incidence of tuberculosis (TB), hepatitis, and hospital-acquired infections.

Geographically, North America dominated the global in vitro diagnostics market in 2015. The large share of this region can be attributed to presence of developed healthcare systems in the U.S. & Canada, increasing acceptance of personalized medicine, and growing adoption of technologically advanced products in this region. The Asia-Pacific region is expected to register the highest CAGR, due to the growth in research activities and increasing investments by leading players and respective government agencies in the region.

The key players in this market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMιrieux (France), and Becton, Dickinson and Company (U.S.), Johnson and Johnson (U.S.), Qiagen N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).

Target Audience

  • IVD Product Manufacturers
  • Group Purchase Organizations (GPOs)
  • Original Equipment Manufacturers (OEM)
  • Pathologists and Pathology Laboratories
  • Distributors of IVD Products
  • Hospitals and Clinics
  • Healthcare Institutions
  • Research Institutes
  • Market Research and Consulting Firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the global in vitro diagnostics market into the following segments:

Global In Vitro Diagnostics Market, by Products and Services

  • Reagents & Kits
  • Instruments
  • Services
  • Data Management Software

Global In Vitro Diagnostics Market, by Technology

  • Clinical Chemistry
    • Basic Metabolic Panel
    • Electrolyte Panel
    • Liver Panel
    • Lipid Profile
    • Renal Profile
    • Thyroid Function Panel
    • Specialty Chemical Tests
  • Immunochemistry/Immunoassay
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence Immunoassay (FIA)
      • Colorimetric Immunoassay (CI)
    • Radioimmunoassays (RIA)
    • Rapid Tests
    • Western Blot
    • ELISPOT
  • Hematology
  • Coagulation & Hemostasis
  • Clinical Microbiology
  • Molecular Diagnostics (MDx)
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Microarrays
    • Hybridization
    • DNA Sequencing & Next-generation Sequencing
    • Other MDx technologies
  • Other Technologies

Global In Vitro Diagnostics Market, by Application

  • Diabetes
  • Infectious Diseases
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • HIV/Aids
  • Other Applications

Global In Vitro Diagnostics Market, by End User

  • Hospitals
  • Laboratories
  • Academic Institutes
  • Point-Of-Care Testing
  • Patient Self-Testing
  • Other End Users

Global In Vitro Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Russia
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • Middle East and Africa

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific in vitro diagnostics market in South Korea, Australia, New Zealand, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 40)
    4.1 In Vitro Diagnostics (IVD): Market Overview
    4.2 Asia-Pacific: In Vitro Diagnostics Market, By Products & Services
    4.3 Geographic Snapshot of the In Vitro Diagnostics Market
    4.4 Geographic Mix: In Vitro Diagnostics Market
    4.5 In Vitro Diagnostics Market: Developing vs Developed Markets

5 Market Overview (Page No. - 45)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Rising Incidence of Chronic Lifestyle Diseases
                    5.2.1.2 Increasing Adoption of Point-Of-Care Testing
                    5.2.1.3 Growing Awareness of Personalized Medicine
                    5.2.1.4 Growth in the Number of Private Diagnostic Centers
           5.2.2 Market Restraints
                    5.2.2.1 Inadequate Reimbursement
                    5.2.2.2 Rising Healthcare Costs and Low Budgets
           5.2.3 Market Opportunities
                    5.2.3.1 Introduction of A New Range of Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
                    5.2.3.2 Emerging Economies With Increasing Investments
                    5.2.3.3 Growing Significance of Companion Diagnostics
           5.2.4 Market Challenges
                    5.2.4.1 Stringent Regulatory Framework
                    5.2.4.2 Operational Barriers for the Use of Diagnostic Tests

6 Industry Insights (Page No. - 56)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Automation of Clinical Laboratory Techniques
           6.2.2 Microfluidics-Based Poc and Loc Diagnostic Devices for Laboratory Testing
           6.2.3 Rise in Reagent Rental Agreements
    6.3 Regulatory Overview
           6.3.1 North America
                    6.3.1.1 U.S.
                    6.3.1.2 Canada
           6.3.2 Europe
           6.3.3 Asia-Pacific
                    6.3.3.1 Japan
                    6.3.3.2 China
                    6.3.3.3 India

7 Global In Vitro Diagnostics Market, By Product & Service (Page No. - 65)
    7.1 Introduction
    7.2 Reagents & Kits
    7.3 Instruments
    7.4 Data Management Software
    7.5 Services

8 Global In Vitro Diagnostics Market, By Technology (Page No. - 74)
    8.1 Introduction
    8.2 Immunochemistry/Immunoassays
           8.2.1 Enzyme-Linked Immunosorbent Assay (ELISA)
                    8.2.1.1 Chemiluminescence Immunoassays (CLIAS)
                    8.2.1.2 Fluorescence Immunoassays (FIAS)
                    8.2.1.3 Colorimetric Immunoassays (CIS)
           8.2.2 Radioimmunoassay (RIA)
           8.2.3 Rapid Tests
           8.2.4 Western Blot
           8.2.5 Enzyme-Linked Immunospot (Elispot) Assay
    8.3 Clinical Chemistry
           8.3.1 Basic Metabolic Panel
           8.3.2 Electrolyte Panel
           8.3.3 Liver Panel
           8.3.4 Lipid Profile
           8.3.5 Renal Profile
           8.3.6 Thyroid Function Panel
           8.3.7 Specialty Chemical Tests
    8.4 Molecular Diagnostics (MDX)
           8.4.1 Polymerase Chain Reaction (PCR)
           8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
           8.4.3 Microarray
           8.4.4 Hybridization
           8.4.5 Dna Sequencing & Next-Generation Sequencing
           8.4.6 Other MDX Technologies
    8.5 Clinical Microbiology
    8.6 Hematology
    8.7 Coagulation and Hemostasis
    8.8 Other IVD Technologies

9 Global In Vitro Diagnostics Market, By Application (Page No. - 114)
    9.1 Introduction
    9.2 Diabetes
    9.3 Infectious Diseases
    9.4 Oncology/Cancer
    9.5 Cardiology
    9.6 Nephrology
    9.7 Autoimmune Diseases
    9.8 Drug Testing/Pharmacogenomics
    9.9 HIV/Aids
    9.10 Other Applications

10 Global In Vitro Diagnostics Market, By End User (Page No. - 132)
     10.1 Introduction
     10.2 Hospitals
     10.3 Laboratories
     10.4 Point-Of-Care Testing
     10.5 Patient Self-Testing
     10.6 Academic Institutes
     10.7 Other End Users

11 Global In Vitro Diagnostics Market, By Region (Page No. - 142)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Russia
             11.3.7 Rest of Europe (RoE)
     11.4 Asia-Pacific (APAC)
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia-Pacific (RoAPAC)
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America (ROLA)
     11.6 Middle East and Africa

12 Competitive Landscape (Page No. - 207)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends
     12.4 New Product Launches
     12.5 Agreements, Partnerships, and Collaborations
     12.6 Acquisitions
     12.7 Expansions
     12.8 Other Strategies

13 Company Profiles (Page No. - 215)
(Overview, Products and Services, Financials, Strategy & Development)*
     13.1 Introduction
     13.2 ABBott Laboratories, Inc.
     13.3 Becton, Dickinson and Company
     13.4 Biomιrieux SA 
     13.5 Bio-Rad Laboratories, Inc.
     13.6 Danaher Corporation
     13.7 Johnson & Johnson
     13.8 Roche Diagnostics
     13.9 Siemens AG
     13.10 Sysmex Corporation
     13.11 Thermo Fisher Scientific, Inc.
     13.12 Ortho-Clinical Diagnostics, Inc.
     13.13 Qiagen N.V.
     13.14 Diasorin S.P.A.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 275)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports
     14.8 Author Details


List of Tables (181 Tables)

Table 1 Global In Vitro Diagnostics Market Snapshot
Table 2 Number of People With Diabetes, By Region, 2015 vs 2040 (Million Individuals)
Table 3 Impact Analysis: Market Drivers
Table 4 Impact Analysis: Market Restraints
Table 5 Impact Analysis: Market Opportunities
Table 6 Impact Analysis: Market Challenges
Table 7 U.S.: Classification of In Vitro Diagnostic Devices
Table 8 U.S.: Time, Cost, and Complexity of Registration Process
Table 9 Canada: Time, Cost, and Complexity of Registration Process
Table 10 Europe: Classification of In Vitro Diagnostic Devices
Table 11 Europe: Time, Cost, and Complexity of Registration Process
Table 12 Japan: Classification of IVD Devices
Table 13 Japan: Time, Cost, and Complexity of Registration Process
Table 14 China: Time, Cost, and Complexity of Registration Process
Table 15 India: Time, Cost, and Complexity of Registration Process
Table 16 Global In Vitro Diagnostics Market, By Product & Service, 2014–2021 (USD Million)
Table 17 Global In Vitro Diagnostics Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 18 Global In Vitro Diagnostics Reagents & Kits Market Size, By Technology, 2014–2021 (USD Million)
Table 19 Global In Vitro Diagnostics Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 20 Global In Vitro Diagnostics Instruments Market Size, By Technology, 2014–2021 (USD Million)
Table 21 Global In Vitro Diagnostics Data Management Software Market Size, By Country, 2014–2021 (USD Million)
Table 22 Global IVD Data Management Software Market Size, By Technology, 2014–2021 (USD Million)
Table 23 Global IVD Services Market Size, By Country, 2014–2021 (USD Million)
Table 24 Global IVD Services Market Size, By Technology, 2014–2021 (USD Million)
Table 25 Global In Vitro Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 26 Global Immunoassay/Immunochemistry Market Size, By Type, 2014–2021 (USD Million)
Table 27 Global In Vitro Diagnostics Market Size for Immunochemistry/Immunoassay, By Country, 2014–2021 (USD Million)
Table 28 Global ELISA Market Size, By Country, 2014–2021 (USD Million)
Table 29 Global ELISA Market Size, By Type, 2014–2021 (USD Million)
Table 30 Global Chemiluminescence Immunoassays Market Size, By Country, 2014–2021 (USD Million)
Table 31 Global Fluorescence Immunoassays Market Size, By Country, 2014–2021 (USD Million)
Table 32 Global Colorimetric Immunoassays Market Size, By Country, 2014–2021 (USD Million)
Table 33 Global Radioimmunoassay Market Size, By Country, 2014–2021 (USD Million)
Table 34 Global Rapid Tests Market Size, By Country, 2014–2021 (USD Million)
Table 35 Global Western Blot Market Size, By Country, 2014–2021 (USD Million)
Table 36 Global Elispot Assay Market Size, By Country, 2014–2021 (USD Million)
Table 37 Global In Vitro Diagnostics Market Size for Clinical Chemistry, By Country, 2014–2021 (USD Million)
Table 38 Global Clinical Chemistry Market Size, By Test Type, 2014–2021 (USD Million)
Table 39 Global Basic Metabolic Panel Market Size, By Country, 2014–2021 (USD Million)
Table 40 Global Electrolyte Panel Market Size, By Country, 2014–2021 (USD Million)
Table 41 Global Liver Panel Market Size, By Country, 2014–2021 (USD Million)
Table 42 Global Lipid Profile Market Size, By Country, 2014–2021 (USD Million)
Table 43 Global Renal Profile Market Size, By Country, 2014–2021 (USD Million)
Table 44 Global Thyroid Function Panel Market Size, By Country, 2014–2021 (USD Million)
Table 45 Global Specialty Chemical Tests Market Size, By Country, 2014–2021 (USD Million)
Table 46 Global In Vitro Diagnostics Market Size for Molecular Diagnostics, By Country, 2014–2021 (USD Million)
Table 47 Global Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 48 Global PCR Market Size for Molecular Diagnostics, By Country, 2014–2021 (USD Million)
Table 49 Global INAAT Market Size for Molecular Diagnostics, By Country, 2014–2021 (USD Million)
Table 50 Global Microarray Market Size for Molecular Diagnostics, By Country, 2014–2021 (USD Million)
Table 51 Global Hybridization Market Size for Molecular Diagnostics, By Country, 2014–2021 (USD Million)
Table 52 Global Dna Sequencing & Ngs Market Size for Molecular Diagnostics, By Country, 2014–2021 (USD Million)
Table 53 Global Other MDX Technologies Market Size, By Country, 2014–2021 (USD Million)
Table 54 Global In Vitro Diagnostics Market Size for Clinical Microbiology, By Country, 2014–2021 (USD Million)
Table 55 Global In Vitro Diagnostics Market Size for Hematology, By Country, 2014–2021 (USD Million)
Table 56 Global In Vitro Diagnostics Market Size for Coagulation & Hemostasis, By Country, 2014–2021 (USD Million)
Table 57 Global Other IVD Technologies Market Size, By Country, 2014–2021 (USD Million)
Table 58 Global In Vitro Diagnostics Market Size, By Application, 2014 – 2021 (USD Million)
Table 59 Global Diabetic Patient Population in 2015 and 2040 (Million)
Table 60 Global In Vitro Diagnostics Market Size for Diabetes, By Country, 2014–2021 (USD Million)
Table 61 Global In Vitro Diagnostics Market Size for Infectious Diseases, By Country, 2014–2021 (USD Million)
Table 62 U.S.: Cancer Incidence Rate, By Region (Per 100,000 Individuals) 2008-2012
Table 63 Global In Vitro Diagnostics Market Size for Oncology/Cancer, By Country, 2014–2021 (USD Million)
Table 64 Global In Vitro Diagnostics Market Size for Cardiology, By Country, 2014–2021 (USD Million)
Table 65 Global In Vitro Diagnostics Market Size for Nephrology, By Country, 2014–2021 (USD Million)
Table 66 Global In Vitro Diagnostics Market Size for Autoimmune Diseases, By Country, 2014–2021 (USD Million)
Table 67 Global In Vitro Diagnostics Market Size for Drug Testing/Pharmacogenomics, By Country, 2014–2021 (USD Million)
Table 68 Global In Vitro Diagnostics Market Size for HIV/Aids, By Country, 2014–2021 (USD Million)
Table 69 Global In Vitro Diagnostics Market Size for Other Applications, By Country, 2014–2021 (USD Million)
Table 70 Global In Vitro Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 71 Global In Vitro Diagnostics Market Size for Hospitals, By Country, 2014–2021 (USD Million)
Table 72 Global In Vitro Diagnostics Market Size for Laboratories, By Country, 2014–2021 (USD Million)
Table 73 Global In Vitro Diagnostics Market Size for Poc Testing, By Country, 2014–2021 (USD Million)
Table 74 Global In Vitro Diagnostics Market Size for Patient Self-Testing, By Country, 2014–2021 (USD Million)
Table 75 Global In Vitro Diagnostics Market Size for Academic Institutes, By Country, 2014–2021 (USD Million)
Table 76 Global In Vitro Diagnostics Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 77 Global In Vitro Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 78 Global In Vitro Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 79 North America: In Vitro Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 80 North America: In Vitro Diagnostics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 81 North America: In Vitro Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 82 North America: In Vitro Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 83 North America: In Vitro Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 84 U.S.: Macroeconomic Indicators
Table 85 U.S.: In Vitro Diagnostics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 86 U.S.: In Vitro Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 87 U.S.: In Vitro Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 88 U.S.: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 89 Canada: Macroeconomic Indicators
Table 90 Canada: IVD Market Size, By Product & Service, 2014–2021 (USD Million)
Table 91 Canada: IVD Market Size, By Application, 2014–2021 (USD Million)
Table 92 Canada: IVD Market Size, By Technology, 2014–2021 (USD Million)
Table 93 Canada: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 94 Europe: IVD Market Size, By Country, 2014–2021 (USD Million)
Table 95 Europe: IVD Market Size, By Product & Service, 2014–2021 (USD Million)
Table 96 Europe: IVD Market Size, By Application, 2014–2021 (USD Million)
Table 97 Europe: IVD Market Size, By Technology, 2014–2021 (USD Million)
Table 98 Europe: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 99 Germany: Macroeconomic Indicators
Table 100 Germany: IVD Market Size, By Product & Service, 2014–2021 (USD Million)
Table 101 Germany: IVD Market Size, By Application, 2014–2021 (USD Million)
Table 102 Germany: IVD Market Size, By Technology, 2014–2021 (USD Million)
Table 103 Germany: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 104 France: Macroeconomic Indicators
Table 105 France: IVD Market Size, By Product & Service, 2014–2021 (USD Million)
Table 106 France: IVD Market Size, By Application, 2014–2021 (USD Million)
Table 107 France: IVD Market Size, By Technology, 2014–2021 (USD Million)
Table 108 France: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 109 U.K.: Macroeconomic Indicators
Table 110 U.K.: IVD Market Size, By Product & Service, 2014–2021 (USD Million)
Table 111 U.K.: IVD Market Size, By Application, 2014–2021 (USD Million)
Table 112 U.K.: IVD Market Size, By Technology, 2014–2021 (USD Million)
Table 113 U.K.: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 114 Italy: Macroeconomic Indicators
Table 115 Italy: IVD Market Size, By Product & Service, 2014–2021 (USD Million)
Table 116 Italy: IVD Market Size, By Application, 2014–2021 (USD Million)
Table 117 Italy: IVD Market Size, By Technology, 2014–2021 (USD Million)
Table 118 Italy: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 119 Spain: Macroeconomic Indicators
Table 120 Spain: IVD Market Size, By Product & Service, 2014–2021 (USD Million)
Table 121 Spain: IVD Market Size, By Application, 2014–2021 (USD Million)
Table 122 Spain: IVD Market Size, By Technology, 2014–2021 (USD Million)
Table 123 Spain: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 124 Russia: IVD Market Size, By Product & Service, 2014–2021 (USD Million)
Table 125 Russia: IVD Market Size, By Application, 2014–2021 (USD Million)
Table 126 Russia: IVD Market Size, By Technology, 2014–2021 (USD Million)
Table 127 Russia: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 128 RoE: IVD Market Size, By Product & Service, 2014–2021 (USD Million)
Table 129 RoE: IVD Market Size, By Application, 2014–2021 (USD Million)
Table 130 RoE: IVD Market Size, By Technology, 2014–2021 (USD Million)
Table 131 RoE: IVD Market Size, By End User, 2014–2021 (USD Million)
Table 132 APAC: IVD Market Size, By Country, 2014-2021 (USD Million)
Table 133 APAC: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 134 APAC: IVD Market Size, By Application, 2014-2021 (USD Million)
Table 135 APAC: IVD Market Size, By Technology, 2014-2021 (USD Million)
Table 136 APAC: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 137 Japan: Macroeconomic Indicators
Table 138 Japan: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 139 Japan: IVD Market Size, By Application, 2014-2021 (USD Million)
Table 140 Japan: IVD Market Size, By Technology, 2014-2021 (USD Million)
Table 141 Japan: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 142 China: Macroeconomic Indicators
Table 143 China: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 144 China: IVD Market Size, By Application, 2014-2021 (USD Million)
Table 145 China: IVD Market Size, By Technology, 2014-2021 (USD Million)
Table 146 China: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 147 India: Macroeconomic Indicators
Table 148 India: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 149 India: IVD Market Size, By Application, 2014-2021 (USD Million)
Table 150 India: IVD Market Size, By Technology, 2014-2021 (USD Million)
Table 151 India: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 152 RoAPAC: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 153 RoAPAC: IVD Market Size, By Application, 2014-2021 (USD Million)
Table 154 RoAPAC: IVD Market Size, By Technology, 2014-2021 (USD Million)
Table 155 RoAPAC: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 156 Latin America: IVD Market Size, By Country, 2014-2021 (USD Million)
Table 157 Latin America: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 158 Latin America: IVD Market Size, By Application, 2014-2021 (USD Million)
Table 159 Latin America: IVD Market Size, By Technology, 2015-2021 (USD Million)
Table 160 Latin America: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 161 Brazil: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 162 Brazil: IVD Market Size, By Application, 2013-2020 (USD Million)
Table 163 Brazil: IVD Market Size, By Technology, 2014-2021 (USD Million)
Table 164 Brazil: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 165 Mexico: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 166 Mexico: IVD Market Size, By Application, 2014-2021 (USD Million)
Table 167 Mexico: IVD Market Size, By Technology, 2014-2021 (USD Million)
Table 168 Mexico: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 169 ROLA: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 170 ROLA: IVD Market Size, By Application, 2014-2021 (USD Million)
Table 171 ROLA: IVD Market Size, By Technology, 2014-2021 (USD Million)
Table 172 ROLA: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 173 Middle East and Africa: IVD Market Size, By Product & Service, 2014-2021 (USD Million)
Table 174 Middle East and Africa: IVD Market Size, By Application, 2014-2021 (USD Million)
Table 175 Middle East and Africa: IVD Market Size, By Technology, 2014-2021 (USD Million)
Table 176 Middle East and Africa: IVD Market Size, By End User, 2014-2021 (USD Million)
Table 177 New Product Launches, 2013–2016
Table 178 Agreements, Partnerships, and Collaborations, 2013–2016
Table 179 Acquisitions, 2013–2016
Table 180 Expansions, 2013–2016
Table 181 Other Developments, 2013–2016


List of Figures (51 Figures)

Figure 1 Global In Vitro Diagnostics Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global IVD Market Size, By Products & Services, 2016 vs 2021 (USD Million)
Figure 7 Global IVD Market Size, By Application, 2016 vs 2021 (USD Million)
Figure 8 Global IVD Market Size, By Technology, 2016 vs 2021 (USD Million)
Figure 9 Global Immunoassay/Immunochemistry Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 10 Global Clinical Chemistry Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 11 Global Molecular Diagnostics Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 12 Global IVD Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 13 Geographic Snapshot of the In Vitro Diagnostics Market
Figure 14 Rising Incidence of Chronic Lifestyle Diseases is Driving Growth of the In Vitro Diagnostics Market
Figure 15 Reagents & Kits Commanded the Largest Share in 2015
Figure 16 The U.S. Accounted for Largest Share of the In Vitro Diagnostics Market in 2015
Figure 17 APAC to Grow at the Highest CAGR in the Forecast Period
Figure 18 Developing Markets to Register A Higher Growth During the Forecast Period
Figure 19 IVD Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Number of People With Chronic Conditions in the U.S.(Million Individuals)
Figure 21 Major Trends in the IVD Market
Figure 22 Canada: Regulatory Process for IVD Devices
Figure 23 Europe: Regulatory Process for IVD Devices
Figure 24 India: Regulatory Process for IVD Devices
Figure 25 Reagents & Kits Segment to Witness the Highest Growth During the Forecast Period
Figure 26 Molecular Diagnostics to Register the Highest CAGR During the Forecast Period
Figure 27 Oncology, the Fastest-Growing Application Segment of the IVD Market
Figure 28 Global HIV Population (2010-2015)
Figure 29 Global In Vitro Diagnostics Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 30 Geographic Snapshot: Markets in Asia-Pacific are Emerging Growth Hotspots
Figure 31 Global IVD Market Share, By Region, 2015 vs 2021
Figure 32 North America: IVD Market Snapshot
Figure 33 U.S.: Chronic Diseases Prevalence (1995-2030)
Figure 34 Europe: IVD Market Snapshot
Figure 35 APAC: IVD Market Snapshot
Figure 36 Players Majorly Adopted the Strategy of Product Launch From 2013 to 2016
Figure 37 Global In Vitro Diagnostics Market Share Analysis, By Key Player, 2015
Figure 38 Battle for Market Share: Product Launch Was the Key Strategy
Figure 39 Geographic Revenue Mix of the Top 5 Market Players
Figure 40 ABBott Laboratories, Inc.: Company Snapshot
Figure 41 Becton, Dickinson and Company: Company Snapshot
Figure 42 Biomιrieux Sa: Company Snapshot
Figure 43 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 44 Danaher Corporation: Company Snapshot
Figure 45 Johnson & Johnson Services, Inc.: Company Snapshot
Figure 46 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 47 Siemens AG: Company Snapshot
Figure 48 Sysmex Corporation: Company Snapshot
Figure 49 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 50 Qiagen N.V.: Company Snapshot
Figure 51 Diasorin S.P.A.: Company Snapshot

The global in vitro diagnostics market is estimated to reach USD 78.74 Billion by 2021, at a CAGR of 5.5% during the forecast period. The growing acceptance of molecular diagnostics for personalized medicine, increase in prevalence of chronic lifestyle diseases, and rise in demand for point-of-care testing are driving market growth. New range of condition-specific markers and tests with advances in genomics & proteomics and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market. However, the rising healthcare costs & lower budgets and inadequate reimbursement are the major restraining factors for this market.

In this report, the market is segmented on the basis of products & services, technology, application, end user, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global in vitro diagnostics market and its submarkets. Based on products & services, the market is segmented into reagents & kits, instruments, services, and data management software. The reagents & kits segment accounted for the largest share of the market in 2015; it is expected to grow at the highest CAGR during the forecast period. Accessibility to a wide range of reagents and the need for reliable, specific, and faster detection of chronic diseases and genetic disorders at early stages are expected to drive the growth of this segment.

Based on end user, in vitro diagnostics market is segmented into hospitals, laboratories, academic institutes, POC (point-of-care) testing, patient self-testing, and others. The hospitals segment accounted for the largest share of the global market in 2015. The large share of this segment can be attributed to the large number of diagnostic tests carried out in hospitals.

In this report, the global market has been studied at the regional and country levels. In 2015, North America represented the largest regional market, followed by Europe. While North America will continue to dominate the market during the forecast period, the Asia-Pacific region is expected to register the highest growth. The growth of this regional segment is driven by the improving healthcare infrastructure, significant economic development in emerging markets, and rising focus of key market players on this region.

In Vitro Diagnostics/IVD Market

The major players in the global in vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMιrieux (France), and Becton, Dickinson and Company (U.S.), Johnson and Johnson (U.S.), Qiagen N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo